SET/TAF-I antibody
Quick Overview for SET/TAF-I antibody (ABIN7118995)
Target
See all SET/TAF-I (SET) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- SET nuclear oncogene
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3 ,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Alternative Name
- SET
-
Background
- Synonyms:SET, 2PP2A, I2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA, protein SET Background:The protein encoded by this gene inhibits acetylation of nucleosomes, especially histone H4, by histone acetylases (HAT). This inhibition is most likely accomplished by masking histone lysines from being acetylated, and the consequence is to silence HAT-dependent transcription. The encoded protein is part of a complex localized to the endoplasmic reticulum but is found in the nucleus and inhibits apoptosis following attack by cytotoxic T lymphocytes. This protein can also enhance DNA replication of the adenovirus genome. Several transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 33 kDa
-
Gene ID
- 6418
-
UniProt
- Q01105
-
Pathways
- Apoptosis
Target
-